Atlas Trials

Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications

Clinical trial NCT04353869 · COMPLETED

Trial details

NCT number
NCT04353869
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
COMPLETED
Study type
OBSERVATIONAL
GlutamineDiabeticCardiovascular Complications
Start date
2020-11-16
Primary completion
2024-01-10
Enrollment
995

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.